Superbugs and the role of diagnostics explainedeucomed
Realising the role of in vitro diagnostics in tackling antibiotic resistance, the European Diagnostic Manufacturers Association (EDMA) in conjunction with AdvamedDx and GMTA hosted a side-event at the WHO’s World Health Assembly “The Fight Against Antimicrobial Resistance: Are Diagnostics Winning?” The event identified existing gaps in tackling AMR while highlighting the role of diagnostics.
So what is the role of diagnostics in antibiotic resistance? Are diagnostics winning?
Superbugs and the role of diagnostics explainedeucomed
Realising the role of in vitro diagnostics in tackling antibiotic resistance, the European Diagnostic Manufacturers Association (EDMA) in conjunction with AdvamedDx and GMTA hosted a side-event at the WHO’s World Health Assembly “The Fight Against Antimicrobial Resistance: Are Diagnostics Winning?” The event identified existing gaps in tackling AMR while highlighting the role of diagnostics.
So what is the role of diagnostics in antibiotic resistance? Are diagnostics winning?
An Antibiotic is given for the treatment of an infection caused by bacteria. Antibiotics target microorganisms such as bacteria, fungi and parasites. However, they are not effective against viruses. If you have an infection it is important to know whether it is caused by bacteria or a virus.
Please find the power point on Antimicrobial resistance. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Antimicrobial resistance as an emerging food-borne infectious diseaseJean Jacques Bernatas
Food safety is also about acquired antimicrobial resistance in big farms, and its spread in the environment. Be a smart consumer, a smart producer, and a smart patient to contributing to get antimicrobial resistance under control.
Antimicrobial Resistance - AMR
A short presentation on Antimicrobial resistance (AMR) on One health day organized in the Cholistan University of Veterinary and Animal Sciences, Bahawalpur by the Department of Zoology. It's a short go through of the topic AMR.
This presentation is made for school health awareness programme on antibiotic resistance. This includes introduction to antibiotics, antibiotic save lives, side effect of antibiotic, and detail about antibiotic resistance. This presentation is mostly focus on antibiotic resistance prevention.
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...Johns Hopkins University
On 12/2/09 on Capitol Hill, leading experts in economics, public health and public policy and Rep. Louise Slaughter (D-NY), a leading voice on antibiotic resistance, discussed the impact of resistant infections on the U.S. healthcare system and the need to phase out inappropriate use of antibiotics as growth promoters in the production of food animals. The Johns Hopkins Center for a Livable Future (CLF) hosted the event with Rep. Slaughter. This is a complication of the panelists' presentations.
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
An Antibiotic is given for the treatment of an infection caused by bacteria. Antibiotics target microorganisms such as bacteria, fungi and parasites. However, they are not effective against viruses. If you have an infection it is important to know whether it is caused by bacteria or a virus.
Please find the power point on Antimicrobial resistance. I tried to present it on understandable way and all the contents are reviewed by experts and from very reliable references. Thank you
Antimicrobial resistance as an emerging food-borne infectious diseaseJean Jacques Bernatas
Food safety is also about acquired antimicrobial resistance in big farms, and its spread in the environment. Be a smart consumer, a smart producer, and a smart patient to contributing to get antimicrobial resistance under control.
Antimicrobial Resistance - AMR
A short presentation on Antimicrobial resistance (AMR) on One health day organized in the Cholistan University of Veterinary and Animal Sciences, Bahawalpur by the Department of Zoology. It's a short go through of the topic AMR.
This presentation is made for school health awareness programme on antibiotic resistance. This includes introduction to antibiotics, antibiotic save lives, side effect of antibiotic, and detail about antibiotic resistance. This presentation is mostly focus on antibiotic resistance prevention.
The Johns Hopkins Center for a Livable Future Capitol Hill Briefing: Antibiot...Johns Hopkins University
On 12/2/09 on Capitol Hill, leading experts in economics, public health and public policy and Rep. Louise Slaughter (D-NY), a leading voice on antibiotic resistance, discussed the impact of resistant infections on the U.S. healthcare system and the need to phase out inappropriate use of antibiotics as growth promoters in the production of food animals. The Johns Hopkins Center for a Livable Future (CLF) hosted the event with Rep. Slaughter. This is a complication of the panelists' presentations.
updated statistics about antimicrobial resistance,causes and mechanism of antimicrobial resistances, national antimicrobial policy, national antimicrobial surveillance, new delhi b metallo-lactamase-1 bacteria
Study about antibiotic abuse in NICU of pediatric department in misurata medical center (MMC) in interval between 1/1/2018 to 28/2/2018 under supervision of community medicine department in faulty of medicine in misurate university
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
1. I was VERY enlightened by participating in a recent CME at
Pushpagiri Medical college, Tiruvella, (1st August 2015) on ANTIBIOTICS, I learnt from many
speakers, that the Antibiotics are going through the last face of survival giving the way for
Simple and commoner bacteria to take over body in a violent from as we call it as
opportunistic infections, we have no way we are pouring antibiotics in the terminal stages of
the patients in ICU’s and MICU’s, unfortunately to simple viral infections, One of the
questions of the enlightened speaker that the life of many Antibiotics is few years then
question remain WHAT NEXT I do not know how long the patient on salvage treatment lives
but creates drug resistant strain in the environment where more healthy and less serious
patients are admitted, It is certain our Hospitals and critical care are areas become the HOT
BED for Hospital associated Microbes spreading all over the vicinity. Before we had
antibiotics, there were few choices when it came to treating infections: You could wait and
see if the infection improved on its own, or you could cut the infection off of your body. It
wasn't until 1928 that the very first antibiotic was discovered -- accidentally, at that -- when
researcher Alexander Fleming came back to work after a weekend away from his lab and
found a certain type of mold, Penicillium notatum, had halted the growth of Staphylococcus.
Not only did it lead to a cure for bacterial infections that were once deadly, but it also led a big
interest in finding new antibiotics. Today many different types of antibiotics are available, and
they fight infection in several ways. And not only did it kill Staphylococcus, it also worked
when he tried it against other bacteria, including Streptococcus, Meningococcai and
Diphtheria bacillus. Antibiotic-resistant bacterial infections take longer to treat and cause
more and longer hospitalizations. Indeed, modern antibiotics act either on processes that are
unique to bacteria--such as the synthesis of cell walls or folic acid--or on bacterium-specific
targets within processes that are common to both bacterium and human cells, including
protein or DNA replication. The CDC estimates that annually more than 2 million Americans
develop antibiotic-resistant infections -- and more than 23,000 people die from these
infections and their complications each year [source: CDC. As an adult human, we have three
to four pounds of beneficial bacteria and yeast living within your intestines. IT JUST MEANS
the bacteria flora in the body is 10 x more than the cells we possess in body these microbes
compete for nutrients from the food we eat. Perhaps you are wondering about the use -- and
abuse -- of antibiotics in general. Let me give you an example. One of the most common
diagnoses given at a doctor’s office is the upper respiratory infection (URI). It accounts for up
to 70 percent of all antibiotics dispensed (Annals of Internal Medicine. American College of
Physicians. American Society of Internal Medicine. March 20, 2001). When you take
antibiotics often or for long periods of time, your risk for long-term health effects increases.
Simply upsetting the balance of resident microbes can have a complex impact on your health
that goes beyond increasing your vulnerability to opportunistic infections. Asking antibiotics
when you have a virus may even hurt you, because it hurts your resident microbes. When
you do need to take an antibiotic, you can help minimize damage to friendly bacteria by
taking one that targets bad bacteria as specifically as possible. This increases the chance
that enough friendly microbes will survive to repopulate their environment and continue to
help you stay healthy. Never forget we are all living healthy with our own normal flora living as
commensals friendly bacteria help keep you healthy in many ways, so when antibiotics kill
friendly bacteria, your health can suffer because you lose these benefits. Additionally, losing
friendly bacteria can give other types of bacteria room to multiply, leading to opportunistic
infection. Sometimes opportunistic infection happens when bacteria from the environment get
into your body and overrun friendly bacteria damaged by an antibiotic. Other times
opportunistic infection begins when antibiotics disturb the balance of your resident microbes,
and normally friendly bacteria multiply too quickly and become harmful. New ECDC data has
shown that there has been a considerable increase over the last four years of combined
resistance to multiple antibiotics in E. coli and Klebsiella pneumonia in over one third of EU
2. and EEA (European Economic Area) nations. Consumption of carbapenems, a major class of
last-line antibiotics, increased significantly from 2007 to 2010. Antibiotic resistance: how has
it become a global threat to public health? Then there is the danger that the ignorant man
may easily undergoes himself and by exposing his microbes to non-lethal quantities of the
drug, make them resistant," said Alexander Fleming, speaking in his Nobel Prize acceptance
speech in 1945. As predicted almost 70 years ago by the man who discovered the first
antibiotic, drug resistance is upon us Even the Microbiology department will be a great source
of misinformation testing the Antibiotics are per whims and fancies of Clinicians who are more
interested in present moment of success leaving the little space next patients and tomorrow,
Even the patients kills the antibiotics with noncompliance as Compliance is a massive
problem. The vast majority of people taking antibiotics are non-compliant. Noncompliance is
the number one reason bacteria develop resistance to antibiotics. According to the
International Journal of Antimicrobial Agents, only one in 10 patients on a three-a-day
regimen take the drug at the right intervals. That means 90% of prescription takers are
breeding more resistant bacteria rather than killing them. No wonder we’re running out of
effective antibiotics.
IF WE DO NOT CONTROL THE MATTERS THE LAST LAUGH IS FORM THE MICROBES
ARE WE READY?
Dr.T.V.Rao MD professor of Microbiology Freelance writer